home / stock / poai / poai news


POAI News and Press, Predictive Oncology Inc. From 05/03/23

Stock Information

Company Name: Predictive Oncology Inc.
Stock Symbol: POAI
Market: NASDAQ
Website: predictive-oncology.com

Menu

POAI POAI Quote POAI Short POAI News POAI Articles POAI Message Board
Get POAI Alerts

News, Short Squeeze, Breakout and More Instantly...

POAI - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Appoints Seasoned Veteran as New Board Member

Predictive Oncology (NASDAQ: POAI) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility to accelerate oncologic drug discovery and enable drug development, a...

POAI - Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors

EAGAN, Minn., May 02, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) l...

POAI - ML and LGMK among mid-day movers

2023-04-25 13:30:38 ET Gainers: CXApp ( CXAI ) +82% . Petros Pharmaceuticals ( PTPI ) +49% . LogicMark ( LGMK ) +28% . Apollomics ( APLM ) +23% . The Aaron's Company ( AAN ) +18% . Baudax Bio ( BXRX ) +18% . Predi...

POAI - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Reverse Stock Split Approved, Effective April 24

Predictive Oncology (NASDAQ: POAI) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility to accelerate oncologic drug discovery and enable drug development, has an...

POAI - Predictive Oncology announces 1-for-20 reverse stock split

2023-04-20 17:24:19 ET Predictive Oncology ( NASDAQ: POAI ) on Thursday said it would effect a 1-for-20 reverse stock split. The stock split will become effective on April 24. "The reverse stock split is primarily intended to bring the Company into compliance with the mini...

POAI - Predictive Oncology Announces Reverse Stock Split

Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023 EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock s...

POAI - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Special Meeting of Stockholders Rescheduled after 'Lack of Required Quorum'

Predictive Oncology (NASDAQ: POAI) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility to accelerate oncologic drug discovery and enable drug development, h...

POAI - Penny Stocks To Buy? 4 Under $1 To Watch Before Next Week

2023-04-14 10:38:00 ET Thanks to key economic data, this has been one of the wildest weeks in the stock market. Whether you’re trading penny stocks or higher-priced companies, it is almost impossible not to notice all macro catalysts in motion. Whether it was March CPI inflation ...

POAI - InvestorNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Names Oncology Translational Research Leader to Scientific Advisory Board

Predictive Oncology (NASDAQ: POAI) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility to accelerate oncologic drug discovery and enable drug development, h...

POAI - Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board

EAGAN, Minn., April 04, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA)...

Previous 10 Next 10